No abstract available
MeSH terms
-
Adenocarcinoma, Follicular* / drug therapy
-
Adenocarcinoma, Follicular* / pathology
-
Carcinoma, Medullary / congenital*
-
Carcinoma, Medullary / drug therapy
-
Carcinoma, Medullary / pathology
-
Carcinoma, Neuroendocrine
-
Carcinoma, Papillary* / drug therapy
-
Carcinoma, Papillary* / pathology
-
Clinical Trials as Topic
-
Dacarbazine / therapeutic use
-
Drug Resistance, Neoplasm / genetics
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Iodine Isotopes / therapeutic use
-
Molecular Targeted Therapy
-
Multiple Endocrine Neoplasia Type 2a* / drug therapy
-
Multiple Endocrine Neoplasia Type 2a* / pathology
-
Neoplasm Metastasis
-
Protein Kinase Inhibitors / therapeutic use*
-
Proto-Oncogene Proteins B-raf / antagonists & inhibitors
-
Thyroid Neoplasms* / drug therapy
-
Thyroid Neoplasms* / pathology
Substances
-
Iodine Isotopes
-
Protein Kinase Inhibitors
-
Dacarbazine
-
BRAF protein, human
-
Proto-Oncogene Proteins B-raf
Supplementary concepts
-
Familial medullary thyroid carcinoma
-
Papillary Thyroid Microcarcinoma
-
Thyroid cancer, medullary